A streamlined metabolic pathway for the biosynthesis of moenomycin A

Chem Biol. 2007 Mar;14(3):257-67. doi: 10.1016/j.chembiol.2007.01.008.


Moenomycin A (MmA) is a member of the phosphoglycolipid family of antibiotics, which are the only natural products known to directly target the extracellular peptidoglycan glycosyltransferases involved in bacterial cell wall biosynthesis. The structural and biological uniqueness of MmA make it an attractive starting point for the development of new antibacterial drugs. In order both to elucidate the biosynthesis of this unusual compound and to develop tools to manipulate its structure, we have identified the MmA biosynthetic genes in Streptomyces ghanaensis (ATCC14672). We show via heterologous expression of a subset of moe genes that the economy of the MmA pathway is enabled through the use of sugar-nucleotide and isoprenoid building blocks derived from primary metabolism. The work reported lays the foundation for genetic engineering of MmA biosynthesis to produce novel derivatives.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacillus cereus / enzymology
  • Bacillus cereus / genetics
  • Bacterial Proteins / metabolism
  • Bambermycins / biosynthesis*
  • Bambermycins / chemistry
  • Carbohydrate Sequence
  • DNA, Bacterial / genetics
  • DNA, Bacterial / isolation & purification
  • Glycosyltransferases / metabolism
  • Kinetics
  • Models, Molecular
  • Molecular Sequence Data
  • Mutagenesis
  • Streptomyces / enzymology*
  • Streptomyces / genetics
  • Transcription, Genetic


  • Bacterial Proteins
  • DNA, Bacterial
  • Bambermycins
  • moenomycin A
  • Glycosyltransferases

Associated data

  • GENBANK/DQ988993
  • GENBANK/DQ988994